Non-Small Cell Lung Cancer

The KEYNOTE B36 study is a Phase 2 pilot, single-arm, open-label study designed to evaluate the safety and effectiveness of Tumor Treating Fields (TTFields), generated by the medical device NovoTTF-200T. Study patients use the device concomitant with pembrolizumab for...

OSC Staff Spotlight: Sherie

What is your role at OSC?Physician Liaison, I have worked at OSC for 6 years. Where are you from and what is your Educational Background?I was born in New York but raised in Charlotte. I am a NC State grad with a degree in Social Work. Why did you choose to work in...